Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California Memorial Hospital East, Shiloh, Illinois Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri Washington University School of Medicine, St Louis, Missouri Siteman Cancer Center-South County, St Louis, Missouri Siteman Cancer Center at Christian Hospital, St Louis, Missouri Canada
University Health Network-Princess Margaret Hospital, Toronto, Ontario